Wordt geladen...
Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma
Although C̄l-inhibitor (C̄l-INH) and α(2)-macroglobulin (α(2)M) have been reported as the major inhibitors of plasma kallikrein in normal plasma, there is little quantitative support for this conclusion. Thus, we studied the inactivation of purified kallikrein in normal plasma, as well as in plasma...
Bewaard in:
| Gepubliceerd in: | J Clin Invest |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Clinical Investigation
1982
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC370996/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6173399/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110470 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|